Like Ipamorelin, GHRP-2 activates the ghrelin receptor at pituitary somatotrophs to directly stimulate GH release
Common Side Effects Gastrointestinal: Nausea, vomiting, abdominal cramps, and diarrhea the most common adverse effects, occurring primarily at doses exceeding 3 g/day [1][5][7]
Shared decision-making between patient and provider should guide therapeutic adjustments, balancing metabolic benefits against tolerability concerns
has provided consultation to Acadia Pharmaceuticals, Acumen Pharmaceuticals, ALZpath, Annovis, Aprinoia Therapeutics, Artery Therapeutics, Biogen, Biohaven, BioXcel, Bristol Myers Squibb, Eisai, Fosun, GAP Foundation, Green Valley, Janssen, Karuna, Kinoxis Therapeutics, Lighthouse Pharmaceuticals, Lilly, Lundbeck, LSP/EQT Life Sciences, Mangrove Therapeutics, Merck, MoCA Cognition, New Amsterdam, Novo Nordisk, OptoCeutics, Otsuka, Oxford Brain Diagnostics, Praxis, Prothena, reMYND, Roche, Scottish Brain Sciences, Signant Health, Simcere, Sinaptica, T-Neuro, TrueBinding and Vaxxinity pharmaceutical, assessment and investment companies
The recommended daily fiber intake for adults taking GLP-1 medications aligns with general population guidelines established by the US Dietary Guidelines for Americans and the National Academies of Sciences, Engineering, and Medicine